Clinical Trials Logo

Cutaneous Tumor clinical trials

View clinical trials related to Cutaneous Tumor.

Filter by:
  • None
  • Page 1

NCT ID: NCT06274905 Completed - Clinical trials for Head and Neck Cancer

Topical Anaesthesia in Cutaneous Head and Neck Surgery

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

This study aims to assess if EMLA or ethyl chloride spray are effective in reducing the pain associated with local anaesthetic administration in cutaneous surgery of the head and neck compared to a placebo and control group through a randomized control trial study design.

NCT ID: NCT06171750 Recruiting - Solid Tumor Clinical Trials

Phase I Study of ANK-101 in Advanced Solid Tumors

ANCHOR
Start date: January 19, 2024
Phase: Phase 1
Study type: Interventional

This is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of ANK-101 in participants with advanced solid tumors who have progressed during or after receiving standard of care (SOC) therapy or who will not benefit from such therapy. The study will be conducted in two parts; Part 1 will enroll participants with superficial lesions and Part 2 will enroll participants with visceral lesions.

NCT ID: NCT05727839 Recruiting - Clinical trials for Malignant Solid Tumor

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Start date: February 24, 2023
Phase: Phase 1
Study type: Interventional

: A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients with Malignant Solid Tumors

NCT ID: NCT05539157 Active, not recruiting - Clinical trials for Malignant Solid Tumor

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Start date: October 18, 2022
Phase: Phase 1
Study type: Interventional

A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients with Malignant Solid Tumors

NCT ID: NCT05340543 Recruiting - Melanoma Clinical Trials

Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)

DERMOCTAV
Start date: December 16, 2021
Phase:
Study type: Observational

This project aims to validate ex vivo the use of the OCTAV® prototype integrating the "dermoscope" function before an in vivo application, by comparing images obtained by the OCTAV® prototype integrating the "dermoscope" function with the histological sections of a skin tumor excision corresponding to them exactly, at the same level.

NCT ID: NCT04068155 Recruiting - Skin Cancer Clinical Trials

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors

NCT ID: NCT03714828 Completed - Clinical trials for Squamous Cell Carcinoma

Study of TVEC in Patients With Cutaneous Squamous Cell Cancer

Start date: December 20, 2018
Phase: Phase 2
Study type: Interventional

This is single arm a Phase 2, single center study of talimogene laherparepvec (TVEC) to treat low risk cutaneous squamous cell carcinomas (cSCC).

NCT ID: NCT03245788 Completed - Breast Cancer Clinical Trials

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study

Start date: February 15, 2017
Phase: N/A
Study type: Interventional

The Stanford Cancer Center is undertaking a Transformation Initiative in order to improve the quality of care and care coordination across the continuum of care. The newest innovation is to introduce lay navigators to specified high-need patients. The larger goal of the project is to assess whether lay navigators can address non-clinical patient needs in a timely fashion and appropriately connect them with their clinical team when warranted. It is expected that proactive interaction with patients will decrease patient anxiety/stress related to their cancer and facilitate higher patient engagement and improved management of physical, social,and emotional health. For the pilot project, the smaller goal is to understand: how lay navigator time is used; the types and frequency of issues brought up by patients; resources that patients are given or referred to; type and frequency of mode of contact with patients; and patients' acceptance of navigators based on refusal. An electronic intake form will be used to collect this information so that data can be analyzed regularly to inform changes to the navigator program as needed.